Industries
|
Companies
|
Filings
|
News
|
CaseLaw
|
Annual Reports
|
UK
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Latest 6-K SEC Filings
Report of foreign issuer [Rules 13a-16 and 15d-16]
NYMOX PHARMACEUTICAL CORP, 6-K, 2000-12-15
NYMOX PHARMACEUTICAL CORP, 6-K, 2000-11-15
TRINITY BIOTECH PLC, 6-K, 2000-11-08
TRINITY BIOTECH PLC, 6-K, 2000-11-02
NYMOX PHARMACEUTICAL CORP, 6-K, 2000-08-18
NYMOX PHARMACEUTICAL CORP, 6-K, 2000-08-14
NYMOX PHARMACEUTICAL CORP, 6-K, 2000-05-15
NYMOX PHARMACEUTICAL CORP, 6-K, 1999-11-15
NYMOX PHARMACEUTICAL CORP, 6-K, 1999-08-10
NYMOX PHARMACEUTICAL CORP, 6-K, 1999-08-06
NYMOX PHARMACEUTICAL CORP, 6-K, 1999-05-19
NYMOX PHARMACEUTICAL CORP, 6-K, 1998-11-13
TRINITY BIOTECH PLC, 6-K, 1998-10-09
NYMOX PHARMACEUTICAL CORP, 6-K, 1998-07-31
NYMOX PHARMACEUTICAL CORP, 6-K, 1998-05-15
NYMOX PHARMACEUTICAL CORP, 6-K, 1997-11-13
NYMOX PHARMACEUTICAL CORP, 6-K, 1997-08-21
FAQ
|
Privacy
|
Terms Of Service
|
Contact
© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission
